APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

C-C Chemokine Receptor Type 4

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global C-C Chemokine Receptor Type 4 Market Outlook and Growth Opportunities 2026

19 December 2025197 pages

Choose your research edition.

Industry ResearchC-C Chemokine Receptor Type 4 Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal C-C Chemokine Receptor Type 4 Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal C-C Chemokine Receptor Type 4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C-C Chemokine Receptor Type 4 Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal C-C Chemokine Receptor Type 4 Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global C-C Chemokine Receptor Type 4 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for C-C Chemokine Receptor Type 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for C-C Chemokine Receptor Type 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for C-C Chemokine Receptor Type 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the C-C Chemokine Receptor Type 4 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the C-C Chemokine Receptor Type 4 market include AstraZeneca Plc, Ono Pharmaceutical Co Ltd, Kyowa Hakko Kirin Co Ltd, Globavir Biosciences Inc, FLX Bio Inc, Corion Biotech Srl, ChemoCentryx Inc and Affitech A/S, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global C-C Chemokine Receptor Type 4 market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of C-C Chemokine Receptor Type 4 and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents C-C Chemokine Receptor Type 4 revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global C-C Chemokine Receptor Type 4 market.

C-C Chemokine Receptor Type 4 Segment by Company

AstraZeneca Plc

Ono Pharmaceutical Co Ltd

Kyowa Hakko Kirin Co Ltd

Globavir Biosciences Inc

FLX Bio Inc

Corion Biotech Srl

ChemoCentryx Inc

Affitech A/S

C-C Chemokine Receptor Type 4 Segment by Type

K-777

GBV-3019

E-0001163

CCX-6239

Others

C-C Chemokine Receptor Type 4 Segment by Application

Central Nervous System

Immunology

Mycosis Fungoides

Others

C-C Chemokine Receptor Type 4 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global C-C Chemokine Receptor Type 4 status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the C-C Chemokine Receptor Type 4 key companies, revenue, market share, and recent developments.

3. To split the C-C Chemokine Receptor Type 4 breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions C-C Chemokine Receptor Type 4 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify C-C Chemokine Receptor Type 4 significant trends, drivers, influence factors in global and regions.

6. To analyze C-C Chemokine Receptor Type 4 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C-C Chemokine Receptor Type 4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C-C Chemokine Receptor Type 4 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C-C Chemokine Receptor Type 4.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global C-C Chemokine Receptor Type 4 industry.

Chapter 3: Detailed analysis of C-C Chemokine Receptor Type 4 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of C-C Chemokine Receptor Type 4 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of C-C Chemokine Receptor Type 4 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. C-C Chemokine Receptor Type 4 Industry Trends Table 2. C-C Chemokine Receptor Type 4 Industry Drivers Table 3. C-C Chemokine Receptor Type 4 Industry Opportunities and Challenges Table 4. C-C Chemokine Receptor Type 4 Industry Restraints Table 5. Global C-C Chemokine Receptor Type 4 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global C-C Chemokine Receptor Type 4 Revenue Share by Company (2021-2026) Table 7. Global C-C Chemokine Receptor Type 4 Company Ranking, (2024-2026) & (US$ Million) Table 8. Global C-C Chemokine Receptor Type 4 Key Company Manufacturing Base & Headquarters Table 9. Global C-C Chemokine Receptor Type 4 Company, Product Type & Application Table 10. Global C-C Chemokine Receptor Type 4 Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global C-C Chemokine Receptor Type 4 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of K-777 Table 15. Significant Companies of GBV-3019 Table 16. Significant Companies of E-0001163 Table 17. Significant Companies of CCX-6239 Table 18. Significant Companies of Others Table 19. Global C-C Chemokine Receptor Type 4 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global C-C Chemokine Receptor Type 4 Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global C-C Chemokine Receptor Type 4 Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global C-C Chemokine Receptor Type 4 Sales Value Share by Type (2021-2026) Table 23. Global C-C Chemokine Receptor Type 4 Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Central Nervous System Table 25. Significant Companies of Immunology Table 26. Significant Companies of Mycosis Fungoides Table 27. Significant Companies of Others Table 28. Global C-C Chemokine Receptor Type 4 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global C-C Chemokine Receptor Type 4 Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global C-C Chemokine Receptor Type 4 Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global C-C Chemokine Receptor Type 4 Sales Value Share by Application (2021-2026) Table 32. Global C-C Chemokine Receptor Type 4 Sales Value Share by Application (2027-2032) Table 33. Global C-C Chemokine Receptor Type 4 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global C-C Chemokine Receptor Type 4 Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global C-C Chemokine Receptor Type 4 Sales Value Share by Region (2021-2026) Table 36. Global C-C Chemokine Receptor Type 4 Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global C-C Chemokine Receptor Type 4 Sales Value Share by Region (2027-2032) Table 38. Global C-C Chemokine Receptor Type 4 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global C-C Chemokine Receptor Type 4 Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global C-C Chemokine Receptor Type 4 Sales Value Market Share by Country (2021-2026) Table 41. Global C-C Chemokine Receptor Type 4 Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global C-C Chemokine Receptor Type 4 Sales Value Market Share by Country (2027-2032) Table 43. AstraZeneca Plc Company Information Table 44. AstraZeneca Plc Business Overview Table 45. AstraZeneca Plc C-C Chemokine Receptor Type 4 Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. AstraZeneca Plc C-C Chemokine Receptor Type 4 Product Portfolio Table 47. AstraZeneca Plc Recent Development Table 48. Ono Pharmaceutical Co Ltd Company Information Table 49. Ono Pharmaceutical Co Ltd Business Overview Table 50. Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Product Portfolio Table 52. Ono Pharmaceutical Co Ltd Recent Development Table 53. Kyowa Hakko Kirin Co Ltd Company Information Table 54. Kyowa Hakko Kirin Co Ltd Business Overview Table 55. Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Product Portfolio Table 57. Kyowa Hakko Kirin Co Ltd Recent Development Table 58. Globavir Biosciences Inc Company Information Table 59. Globavir Biosciences Inc Business Overview Table 60. Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Product Portfolio Table 62. Globavir Biosciences Inc Recent Development Table 63. FLX Bio Inc Company Information Table 64. FLX Bio Inc Business Overview Table 65. FLX Bio Inc C-C Chemokine Receptor Type 4 Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. FLX Bio Inc C-C Chemokine Receptor Type 4 Product Portfolio Table 67. FLX Bio Inc Recent Development Table 68. Corion Biotech Srl Company Information Table 69. Corion Biotech Srl Business Overview Table 70. Corion Biotech Srl C-C Chemokine Receptor Type 4 Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Corion Biotech Srl C-C Chemokine Receptor Type 4 Product Portfolio Table 72. Corion Biotech Srl Recent Development Table 73. ChemoCentryx Inc Company Information Table 74. ChemoCentryx Inc Business Overview Table 75. ChemoCentryx Inc C-C Chemokine Receptor Type 4 Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. ChemoCentryx Inc C-C Chemokine Receptor Type 4 Product Portfolio Table 77. ChemoCentryx Inc Recent Development Table 78. Affitech A/S Company Information Table 79. Affitech A/S Business Overview Table 80. Affitech A/S C-C Chemokine Receptor Type 4 Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Affitech A/S C-C Chemokine Receptor Type 4 Product Portfolio Table 82. Affitech A/S Recent Development Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. C-C Chemokine Receptor Type 4 Product Image Figure 2. Global C-C Chemokine Receptor Type 4 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global C-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 4. Global C-C Chemokine Receptor Type 4 Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. K-777 Image Figure 8. GBV-3019 Image Figure 9. E-0001163 Image Figure 10. CCX-6239 Image Figure 11. Others Image Figure 12. Global C-C Chemokine Receptor Type 4 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global C-C Chemokine Receptor Type 4 Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global C-C Chemokine Receptor Type 4 Sales Value Share by Type (2021-2032) Figure 15. Central Nervous System Image Figure 16. Immunology Image Figure 17. Mycosis Fungoides Image Figure 18. Others Image Figure 19. Global C-C Chemokine Receptor Type 4 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global C-C Chemokine Receptor Type 4 Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global C-C Chemokine Receptor Type 4 Sales Value Share by Application (2021-2032) Figure 22. Global C-C Chemokine Receptor Type 4 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global C-C Chemokine Receptor Type 4 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America C-C Chemokine Receptor Type 4 Sales Value (2021-2032) & (US$ Million) Figure 25. North America C-C Chemokine Receptor Type 4 Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe C-C Chemokine Receptor Type 4 Sales Value (2021-2032) & (US$ Million) Figure 27. Europe C-C Chemokine Receptor Type 4 Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific C-C Chemokine Receptor Type 4 Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific C-C Chemokine Receptor Type 4 Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America C-C Chemokine Receptor Type 4 Sales Value (2021-2032) & (US$ Million) Figure 31. South America C-C Chemokine Receptor Type 4 Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa C-C Chemokine Receptor Type 4 Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa C-C Chemokine Receptor Type 4 Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • K-777
  • GBV-3019
  • E-0001163
  • CCX-6239
  • Others
Applications
  • Central Nervous System
  • Immunology
  • Mycosis Fungoides
  • Others
Companies covered
  • AstraZeneca Plc
  • Ono Pharmaceutical Co Ltd
  • Kyowa Hakko Kirin Co Ltd
  • Globavir Biosciences Inc
  • FLX Bio Inc
  • Corion Biotech Srl
  • ChemoCentryx Inc
  • Affitech A/S

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global C-C Chemokine Receptor Type 4 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global C-C Chemokine Receptor Type 4 Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 C-C Chemokine Receptor Type 4 Market Dynamics
  1. 2.1 C-C Chemokine Receptor Type 4 Industry Trends
  2. 2.2 C-C Chemokine Receptor Type 4 Industry Drivers
  3. 2.3 C-C Chemokine Receptor Type 4 Industry Opportunities and Challenges
  4. 2.4 C-C Chemokine Receptor Type 4 Industry Restraints
3 C-C Chemokine Receptor Type 4 Market by Company
  1. 3.1 Global C-C Chemokine Receptor Type 4 Company Revenue Ranking in 2025
  2. 3.2 Global C-C Chemokine Receptor Type 4 Revenue by Company (2021-2026)
  3. 3.3 Global C-C Chemokine Receptor Type 4 Company Ranking (2024-2026)
  4. 3.4 Global C-C Chemokine Receptor Type 4 Company Manufacturing Base and Headquarters
  5. 3.5 Global C-C Chemokine Receptor Type 4 Company Product Type and Application
  6. 3.6 Global C-C Chemokine Receptor Type 4 Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global C-C Chemokine Receptor Type 4 Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 C-C Chemokine Receptor Type 4 Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 C-C Chemokine Receptor Type 4 Market by Type
  1. 4.1 C-C Chemokine Receptor Type 4 Type Introduction
  2. 4.1.1 K-777
  3. 4.1.2 GBV-3019
  4. 4.1.3 E-0001163
  5. 4.1.4 CCX-6239
  6. 4.1.5 Others
  7. 4.2 Global C-C Chemokine Receptor Type 4 Sales Value by Type
  8. 4.2.1 Global C-C Chemokine Receptor Type 4 Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global C-C Chemokine Receptor Type 4 Sales Value by Type (2021-2032)
  10. 4.2.3 Global C-C Chemokine Receptor Type 4 Sales Value Share by Type (2021-2032)
5 C-C Chemokine Receptor Type 4 Market by Application
  1. 5.1 C-C Chemokine Receptor Type 4 Application Introduction
  2. 5.1.1 Central Nervous System
  3. 5.1.2 Immunology
  4. 5.1.3 Mycosis Fungoides
  5. 5.1.4 Others
  6. 5.2 Global C-C Chemokine Receptor Type 4 Sales Value by Application
  7. 5.2.1 Global C-C Chemokine Receptor Type 4 Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global C-C Chemokine Receptor Type 4 Sales Value by Application (2021-2032)
  9. 5.2.3 Global C-C Chemokine Receptor Type 4 Sales Value Share by Application (2021-2032)
6 C-C Chemokine Receptor Type 4 Regional Value Analysis
  1. 6.1 Global C-C Chemokine Receptor Type 4 Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global C-C Chemokine Receptor Type 4 Sales Value by Region (2021-2032)
  3. 6.2.1 Global C-C Chemokine Receptor Type 4 Sales Value by Region: 2021-2026
  4. 6.2.2 Global C-C Chemokine Receptor Type 4 Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America C-C Chemokine Receptor Type 4 Sales Value (2021-2032)
  7. 6.3.2 North America C-C Chemokine Receptor Type 4 Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe C-C Chemokine Receptor Type 4 Sales Value (2021-2032)
  10. 6.4.2 Europe C-C Chemokine Receptor Type 4 Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific C-C Chemokine Receptor Type 4 Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific C-C Chemokine Receptor Type 4 Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America C-C Chemokine Receptor Type 4 Sales Value (2021-2032)
  16. 6.6.2 South America C-C Chemokine Receptor Type 4 Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa C-C Chemokine Receptor Type 4 Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa C-C Chemokine Receptor Type 4 Sales Value Share by Country, 2025 VS 2032
7 C-C Chemokine Receptor Type 4 Country-level Value Analysis
  1. 7.1 Global C-C Chemokine Receptor Type 4 Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global C-C Chemokine Receptor Type 4 Sales Value by Country (2021-2032)
  3. 7.2.1 Global C-C Chemokine Receptor Type 4 Sales Value by Country (2021-2026)
  4. 7.2.2 Global C-C Chemokine Receptor Type 4 Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt C-C Chemokine Receptor Type 4 Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt C-C Chemokine Receptor Type 4 Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt C-C Chemokine Receptor Type 4 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AstraZeneca Plc
  2. 8.1.1 AstraZeneca Plc Company Information
  3. 8.1.2 AstraZeneca Plc Business Overview
  4. 8.1.3 AstraZeneca Plc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AstraZeneca Plc C-C Chemokine Receptor Type 4 Product Portfolio
  6. 8.1.5 AstraZeneca Plc Recent Developments
  7. 8.2 Ono Pharmaceutical Co Ltd
  8. 8.2.1 Ono Pharmaceutical Co Ltd Company Information
  9. 8.2.2 Ono Pharmaceutical Co Ltd Business Overview
  10. 8.2.3 Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Product Portfolio
  12. 8.2.5 Ono Pharmaceutical Co Ltd Recent Developments
  13. 8.3 Kyowa Hakko Kirin Co Ltd
  14. 8.3.1 Kyowa Hakko Kirin Co Ltd Company Information
  15. 8.3.2 Kyowa Hakko Kirin Co Ltd Business Overview
  16. 8.3.3 Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Product Portfolio
  18. 8.3.5 Kyowa Hakko Kirin Co Ltd Recent Developments
  19. 8.4 Globavir Biosciences Inc
  20. 8.4.1 Globavir Biosciences Inc Company Information
  21. 8.4.2 Globavir Biosciences Inc Business Overview
  22. 8.4.3 Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Product Portfolio
  24. 8.4.5 Globavir Biosciences Inc Recent Developments
  25. 8.5 FLX Bio Inc
  26. 8.5.1 FLX Bio Inc Company Information
  27. 8.5.2 FLX Bio Inc Business Overview
  28. 8.5.3 FLX Bio Inc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (2021-2026)
  29. 8.5.4 FLX Bio Inc C-C Chemokine Receptor Type 4 Product Portfolio
  30. 8.5.5 FLX Bio Inc Recent Developments
  31. 8.6 Corion Biotech Srl
  32. 8.6.1 Corion Biotech Srl Company Information
  33. 8.6.2 Corion Biotech Srl Business Overview
  34. 8.6.3 Corion Biotech Srl C-C Chemokine Receptor Type 4 Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Corion Biotech Srl C-C Chemokine Receptor Type 4 Product Portfolio
  36. 8.6.5 Corion Biotech Srl Recent Developments
  37. 8.7 ChemoCentryx Inc
  38. 8.7.1 ChemoCentryx Inc Company Information
  39. 8.7.2 ChemoCentryx Inc Business Overview
  40. 8.7.3 ChemoCentryx Inc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ChemoCentryx Inc C-C Chemokine Receptor Type 4 Product Portfolio
  42. 8.7.5 ChemoCentryx Inc Recent Developments
  43. 8.8 Affitech A/S
  44. 8.8.1 Affitech A/S Company Information
  45. 8.8.2 Affitech A/S Business Overview
  46. 8.8.3 Affitech A/S C-C Chemokine Receptor Type 4 Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Affitech A/S C-C Chemokine Receptor Type 4 Product Portfolio
  48. 8.8.5 Affitech A/S Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst